Revenue
attach_money981M CNY
YoY +341.8%
ASPHFAscentage Pharma Group International$ --
Ascentage Pharma Group International
ASPHF
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart-370M CNY
YoY +57.6%
Net Income
verified-405M CNY
YoY +56.2%
EPS
pie_chart-1.37CNY
YoY +58.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress11.3%Below Target
Revenue Progress32M
Revenue Forecast528.7M
Net Income Progress-80.8M
Net Income Forecast-713.4M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.